about
Acupuncture in the treatment of rheumatic diseasesA System Computational Model of Implicit Emotional Learning.Effects of acupuncture treatment on poststroke motor recovery and physical function: a pilot study.Biological, clinical, and ethical advances of placebo effects.Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation.Prediction of placebo responses: a systematic review of the literature.Assessing mobility at home in people with early Parkinson's disease using an instrumented Timed Up and Go test.Placebo effect of medication cost in Parkinson disease: a randomized double-blind studyα6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.Unexpected dual task benefits on cycling in Parkinson disease and healthy adults: a neuro-behavioral model.Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's diseaseAntidepressant studies in Parkinson's disease: a review and meta-analysis.Mechanisms of the placebo effect and of conditioning.Reviving the old sermon of medicine with the placebo effect.Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trialPlacebo theory and its implications for research and clinical practice: a review of the recent literature.Varenicline-Induced Elevation of Dopamine in Smokers: A Preliminary [(11)C]-(+)-PHNO PET Study.Placebo and nocebo effects: a complex interplay between psychological factors and neurochemical networks.Perspective on the Road toward Gene Therapy for Parkinson's Disease.Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.Genetic biomarkers of placebo response: what could it mean for future trial design?Patient expectations in placebo-controlled randomized clinical trials.Intranasal Dopamine Reduces In Vivo [(123)I]FP-CIT Binding to Striatal Dopamine Transporter: Correlation with Behavioral Changes and Evidence for Pavlovian Conditioned Dopamine Response.Levodopa effects on [ (11)C]raclopride binding in the resting human brainPlacebo Response is Driven by UCS Revaluation: Evidence, Neurophysiological Consequences and a Quantitative Model.Potential cellular and regenerative approaches for the treatment of Parkinson's disease.Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: Results of a three-arm randomized controlled trial.Effectiveness of Rotigotine plus intensive and goal-based rehabilitation versus Rotigotine alone in "de-novo" Parkinsonian subjects: a randomized controlled trial with 18-month follow-up.Effectiveness of intensive inpatient rehabilitation treatment on disease progression in parkinsonian patients: a randomized controlled trial with 1-year follow-up.Improvements in rate of development and magnitude of force with intense auditory stimuli in patients with Parkinson's disease.Homeopathy and placebo--synonym, similar or different?Enhancing Placebo Effects in Somatic Symptoms Through Oxytocin.Adjunct rasagiline to treat Parkinson’s disease with motor fluctuations: a randomized, double-blind study in China.Effects of tapentadol on pain, motor symptoms and cognitive functions in Parkinson's diseasePlacebo: no longer a phantom responseCharacteristics of women with nausea and vomiting of pregnancy who chose to continue compassionate use of placebo after a randomised trial
P2860
Q24608964-3AB7E739-D07A-44D6-93EA-67A43046E652Q27318577-5478F783-48C0-487E-8282-2E11D3E7FBDBQ33208866-6CDE8D8F-C367-49E6-A9CB-703A6CB5072DQ33703954-F2C69969-1927-4ADE-B09A-3C13620734E7Q34258319-F791A904-C4A4-4B02-85E2-01AF835D7C90Q34272476-AD6C6A7D-DDCD-4308-BEA2-5CD99792D2F2Q34372643-4D331696-085C-4864-971F-3E2B55B43409Q35134917-04367C99-DEDA-423D-873B-47FE44D13C20Q35264378-81A25D32-257D-47C4-9131-B7ABCAE8F94DQ35630608-7332EB72-1ADB-4474-8387-DA4B2E81FA72Q35932749-6F2B34E2-F802-4B03-B1F3-D45545113437Q36008775-C5213A8A-05F3-42FB-B3FF-36E07855134EQ36180267-69E20553-93A1-4A1C-893D-635A917F4443Q36343673-2E6CFAEE-1B7A-4CFC-85E6-77DB520F3190Q36368880-EA397A56-CA4D-44DD-AAC2-3E7342C8AD98Q36738105-E6FFFC4D-1EC8-4268-A22C-F5EB8BF57362Q36798993-9E386AA9-C248-4B37-BAD3-AB8B5398D61BQ38451549-1EF09F36-AA36-4BC4-9BC8-49BA4834ACA1Q38719576-7FC90D23-B048-4329-98A7-0267DBE516ABQ38865983-4DAA9670-BC3F-4492-85F7-25AE01561F27Q39293085-EAE338F6-71A2-49A6-9F37-1C8C06253AB6Q39347818-D9B5F17D-EA6F-4803-A0DF-9C8D2A43B92BQ39705445-42FB4D8D-A9FD-4D37-ABE2-380D46122994Q40469907-0113CD31-0500-43DD-B4CE-B8F222EF3F5CQ40730465-78DB4969-626F-4D15-9278-208B83F77E3AQ42205803-AE2C0DA1-87C8-4617-BE61-6F14EF350718Q43198086-E059D8D6-9835-413D-AB1E-9E01AB71DDBEQ48113811-37AB915B-CE83-474C-B276-8DBA36201E83Q50016908-58F29DF4-49E8-4D49-B4E8-E54FE5356593Q51857569-3610013D-387B-41EA-89D9-4136846AAA70Q51865061-0CC39561-BDF1-4C13-BE69-FB3FBD53273EQ52923523-07BB7DAF-39FD-461B-B703-9543034EEC47Q53419422-75ED2CAB-3343-404D-B41F-2A2147EE871FQ55516146-25BA57BD-6245-4F1F-BC71-EB46F35E1C2DQ57111444-2DB25473-4593-4234-BC47-99ABC02F0544Q58350916-B5A1AFE3-5BAD-4838-864D-C3F80D8684E6Q58392235-12147571-1114-43A5-95BA-5C17FD5D797C
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The placebo effect in Parkinson's disease.
@ast
The placebo effect in Parkinson's disease.
@en
The placebo effect in Parkinson's disease.
@nl
type
label
The placebo effect in Parkinson's disease.
@ast
The placebo effect in Parkinson's disease.
@en
The placebo effect in Parkinson's disease.
@nl
prefLabel
The placebo effect in Parkinson's disease.
@ast
The placebo effect in Parkinson's disease.
@en
The placebo effect in Parkinson's disease.
@nl
P1476
The placebo effect in Parkinson's disease.
@en
P2093
A Jon Stoessl
Raúl de la Fuente-Fernández
P304
P356
10.1016/S0166-2236(02)02181-1
P577
2002-06-01T00:00:00Z